Retina Consultant

At the Envision Summit 2025 in San Juan, Puerto Rico, Mike Farkas, MD, discussed gene therapy research for retinal degenerations that sidetracks the current “status quo” therapies of AAV-based replacement and CRISPR-Cas9 genome editing. Video Transcript:Editor’s note: The below transcript has been lightly edited for clarity.Mike Farkas, MD:I’m Mike Farkas, I’m an associate professor at…

Continue Reading Envision Summit 2025: Beyond the status quo in gene therapy

Thomas W. Samuelson, MD, sat down with Sheryl Stevenson, executive editor of Ophthalmology Times, to discuss recent advancements in ophthalmic laser technology, such as the Voyager direct selective laser trabeculoplasty (DSLT) (Alcon). As an attending surgeon and founding partner of Minnesota Eye Consultants in Minneapolis, Samuelson…

Continue Reading Thomas W. Samuelson, MD, shares clinical perspectives on DSLT, SLT, and glaucoma management

At the Envision Summit 2025 in San Juan, Puerto Rico, Kelly Donovan, MD, talked about her graduate research on the earliest phase of diabetic retinopathy, and trying to understand how hyperglycemia translates into disease.Video Transcript:Editor’s note: The below transcript has been lightly edited for clarity.Kelly Donovan,…

Continue Reading Envision Summit 2025: Understanding hyperglycemia in diabetic retinopathy

A study conducted at major ophthalmology departments across the US found that the rates of sexual harassment in the specialty, which were high when a previous survey was conducted, remained high 5 years after those high rates were disclosed, with higher frequencies of recent experiences and…

Continue Reading Sexual harassment remains high in ophthalmology

At the Envision Summit 2025 in San Juan, Puerto Rico, Oleg Alekseev, MD, PhD, talked about difficulties in diagnosing inherited retinal degenerations due to mutations in over 300 different genes.Video Transcript:Editor’s note: The below transcript has been lightly edited for clarity.Oleg Alekseev, MD, PhD:My name is…

Continue Reading Envision Summit 2025: Difficulties in diagnosing inherited retinal degenerations